122 related articles for article (PubMed ID: 2967752)
1. Regression of left ventricular hypertrophy during combined atenolol and nifedipine treatment.
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Drugs; 1988; 35 Suppl 4():39-43. PubMed ID: 2967752
[TBL] [Abstract][Full Text] [Related]
2. Regression of left ventricular hypertrophy by acebutolol and nifedipine.
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Cardiovasc Drugs Ther; 1989 Jun; 3 Suppl 1():313-7. PubMed ID: 2535068
[TBL] [Abstract][Full Text] [Related]
3. Preserved ventricular pump function after a marked reduction of left ventricular mass.
Ketelhut R; Franz IW; Behr U; Toennesmann U; Messerli FH
J Am Coll Cardiol; 1992 Oct; 20(4):864-8. PubMed ID: 1356116
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of antihypertensive therapy on left ventricular hypertrophy.
Franz IW; Tönnesmann U; Behr U; Ketelhut R
J Hypertens Suppl; 1987 Dec; 5(5):S415-8. PubMed ID: 2965229
[TBL] [Abstract][Full Text] [Related]
5. Effects of nifedipine-GITS on left ventricular mass and left ventricular filling.
Phillips RA; Ardeljan M; Shimabukuro S; Goldman ME; Garbowit DL; Eison HB; Krakoff LR
J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S28-34. PubMed ID: 1377301
[TBL] [Abstract][Full Text] [Related]
6. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
Daniels AR; Opie LH
Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
[TBL] [Abstract][Full Text] [Related]
7. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
[TBL] [Abstract][Full Text] [Related]
8. [Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Z Kardiol; 1989; 78 Suppl 5():43-8. PubMed ID: 2561036
[TBL] [Abstract][Full Text] [Related]
9. Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension. Reversal by atenolol treatment.
Corea L; Bentivoglio M; Verdecchia P
Hypertension; 1983; 5(6):837-43. PubMed ID: 6228528
[TBL] [Abstract][Full Text] [Related]
10. Effects of atenolol on left ventricular hypertrophy and early left ventricular function in essential hypertension.
Allen JW; Kaiser PJ; Montenegro A
Am J Cardiol; 1989 Nov; 64(18):1157-61. PubMed ID: 2530892
[TBL] [Abstract][Full Text] [Related]
11. The effects of antihypertensive therapy on left ventricular mass in elderly patients.
Schulman SP; Weiss JL; Becker LC; Gottlieb SO; Woodruff KM; Weisfeldt ML; Gerstenblith G
N Engl J Med; 1990 May; 322(19):1350-6. PubMed ID: 2139175
[TBL] [Abstract][Full Text] [Related]
12. Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol.
Dunn FG; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
Circulation; 1987 Aug; 76(2):254-8. PubMed ID: 2955954
[TBL] [Abstract][Full Text] [Related]
13. Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.
Maclean D; Mitchell ET; Coulson RR; Fitzsimons TJ; McDevitt DG
Br J Clin Pharmacol; 1988 Apr; 25(4):425-31. PubMed ID: 3289598
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
Nifedipine-Atenolol Study Review Committee
Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
[TBL] [Abstract][Full Text] [Related]
15. Regression of left ventricular hypertrophy from systemic hypertension by gallopamil.
Franz IW; Behr U; Ketelhut R; Agrawal B
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S178-81. PubMed ID: 2455127
[TBL] [Abstract][Full Text] [Related]
16. [Regression of left ventricular hypertrophy in hypertensive patients under long-term therapy with antihypertensive agents].
Franz IW; Tönnesmann U; Behr U; Ketelhut R
Dtsch Med Wochenschr; 1990 Apr; 115(16):603-9. PubMed ID: 2139409
[TBL] [Abstract][Full Text] [Related]
17. [Effects of calcium antagonists or beta-blockade on left ventricular diastolic function in essential hypertension].
Shiotani M; Arita M; Nakatsu C; Nakamura N; Ohshika H; Nakamura Y; Fujiwara S; Ueno Y; Nishio I; Masuyama Y
J Cardiol; 1990; 20(1):135-45. PubMed ID: 2093746
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of atenolol, nifedipine and their combination in the treatment of hypertension.
Smith DH; Neutel JM; Jankelow D; Pretorius JJ; Myburgh DP
S Afr Med J; 1991 Jan; 79(1):12-5. PubMed ID: 1986440
[TBL] [Abstract][Full Text] [Related]
19. Aims of combination therapy--improved quality of life or better blood pressure control?
Maclean D
Drugs; 1988; 35 Suppl 4():16-21. PubMed ID: 3378514
[TBL] [Abstract][Full Text] [Related]
20. Effects of labetalol on left ventricular mass and function in hypertension--an assessment by serial echocardiography.
Kaul U; Mohan JC; Bhatia ML
Int J Cardiol; 1984 Apr; 5(4):461-73. PubMed ID: 6233228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
